US46186M6057 - Common Stock
INVIVO THERAPEUTICS HOLDINGS
NASDAQ:NVIV (2/12/2024, 7:01:31 PM)
After market: 0.231 -0.09 (-27.97%)0.3207
-0.17 (-34.28%)
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is headquartered in Cambridge, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2006-11-14. The firm's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. The company is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.
INVIVO THERAPEUTICS HOLDINGS
Building 1400 East 4Th Floor, One Kendall Square
Cambridge MASSACHUSETTS 02139
P: 16178635524
CEO: Richard Toselli
Employees: 6
Website: https://www.invivotherapeutics.com/
We're starting Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
DocuSign layoffs are coming for 6% of the company's employees as it reduces its Sales & Marketing headcount in a restructuring plan.
Trio Petroleum stock is falling on Tuesday as TPET investors react to it amending a securities purchase agreement with an investor.
Peraso stock is falling on Tuesday after the semiconductor company announced details for a proposed public offering of PRSO shares.
Chenghe Acquisition stock is rallying on Tuesday after the company reached a Forward Purchase Agreement with sellers for CHEA shares.
InVivo Therapeutics stock is rising on Tuesday with heavy trading of NVIV shares as they remain volatile after a recent bankruptcy filing.
Here you can normally see the latest stock twits on NVIV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: